These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 18941464)

  • 21. PPARγ agonist rosiglitazone inhibits migration and invasion by downregulating Cyr61 in rheumatoid arthritis fibroblast-like synoviocytes.
    Kwon EJ; Park EJ; Choi S; Kim SR; Cho M; Kim J
    Int J Rheum Dis; 2017 Oct; 20(10):1499-1509. PubMed ID: 27456070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyr61 is a target for heparin in reducing MV3 melanoma cell adhesion and migration via the integrin VLA-4.
    Schmitz P; Gerber U; Schütze N; Jüngel E; Blaheta R; Naggi A; Torri G; Bendas G
    Thromb Haemost; 2013 Nov; 110(5):1046-54. PubMed ID: 24009013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer.
    Ding G; Fang J; Tong S; Qu L; Jiang H; Ding Q; Liu J
    Prostate; 2015 Jun; 75(9):957-68. PubMed ID: 25728945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The importance of the CXCL12-CXCR4 chemokine ligand-receptor interaction in prostate cancer metastasis.
    Arya M; Patel HR; McGurk C; Tatoud R; Klocker H; Masters J; Williamson M
    J Exp Ther Oncol; 2004 Dec; 4(4):291-303. PubMed ID: 15844659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-564 inhibited metastasis and proliferation of prostate cancer by targeting MLLT3.
    Meng FJ; Meng FM; Wu HX; Cao XF
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4828-4834. PubMed ID: 29164580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined treatment with troglitazone and lovastatin inhibited epidermal growth factor-induced migration through the downregulation of cysteine-rich protein 61 in human anaplastic thyroid cancer cells.
    Chin LH; Hsu SP; Zhong WB; Liang YC
    PLoS One; 2015; 10(3):e0118674. PubMed ID: 25742642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Notch-4 silencing inhibits prostate cancer growth and EMT via the NF-κB pathway.
    Zhang J; Kuang Y; Wang Y; Xu Q; Ren Q
    Apoptosis; 2017 Jun; 22(6):877-884. PubMed ID: 28374086
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TGF-β Effects on Prostate Cancer Cell Migration and Invasion Require FosB.
    Barrett CS; Millena AC; Khan SA
    Prostate; 2017 Jan; 77(1):72-81. PubMed ID: 27604827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the anticancer and anti-metastasis effects of novel synthetic sodium channel blockers in prostate cancer cells in vitro and in vivo.
    Wang J; Lu Z; Wu C; Li Y; Kong Y; Zhou R; Shi K; Guo J; Li N; Liu J; Song W; Wang H; Zhu M; Xu H
    Prostate; 2019 Jan; 79(1):62-72. PubMed ID: 30242862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of Cyr61 in the growth, invasiveness and adhesion of esophageal squamous cell carcinoma cells.
    Xie JJ; Xu LY; Xie YM; Du ZP; Feng CH; Dong H; Li EM
    Int J Mol Med; 2011 Mar; 27(3):429-34. PubMed ID: 21249313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Invasion and increased expression of S100A4 and CYR61 in mesenchymal transformed breast cancer cells is downregulated by GnRH.
    Gründker C; Bauerschmitz G; Schubert A; Emons G
    Int J Oncol; 2016 Jun; 48(6):2713-21. PubMed ID: 27098123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel anti-Cyr61 antibody inhibits breast cancer growth and metastasis in vivo.
    Lin J; Huo R; Wang L; Zhou Z; Sun Y; Shen B; Wang R; Li N
    Cancer Immunol Immunother; 2012 May; 61(5):677-87. PubMed ID: 22048717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of aberrantly activated HOTAIR/EZH2/miR-193a feedback loop in progression of prostate cancer.
    Ling Z; Wang X; Tao T; Zhang L; Guan H; You Z; Lu K; Zhang G; Chen S; Wu J; Qian J; Liu H; Xu B; Chen M
    J Exp Clin Cancer Res; 2017 Nov; 36(1):159. PubMed ID: 29141691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyr61 is regulated by cAMP-dependent protein kinase with serum levels correlating with prostate cancer aggressiveness.
    Terada N; Shiraishi T; Zeng Y; Mooney SM; Yeater DB; Mangold LA; Partin AW; Kulkarni P; Getzenberg RH
    Prostate; 2012 Jun; 72(9):966-76. PubMed ID: 22025384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity.
    Hua D; Liu MY; Cheng ZD; Qin XJ; Zhang HM; Chen Y; Qin GJ; Liang G; Li JN; Han XF; Liu DX
    Mol Immunol; 2009 Sep; 46(15):2876-84. PubMed ID: 19643479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dexamethasone Inhibits TGF-β1-Induced Cell Migration by Regulating the ERK and AKT Pathways in Human Colon Cancer Cells Via CYR61.
    Han S; Bui NT; Ho MT; Kim YM; Cho M; Shin DB
    Cancer Res Treat; 2016 Jul; 48(3):1141-53. PubMed ID: 26693911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disabled homolog 2 is required for migration and invasion of prostate cancer cells.
    Xie Y; Zhang Y; Jiang L; Zhang M; Chen Z; Liu D; Huang Q
    Front Med; 2015 Sep; 9(3):312-21. PubMed ID: 26143155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The ubiquitin ligase UBE4A inhibits prostate cancer progression by targeting interleukin-like EMT inducer (ILEI).
    Sun Y; Jia X; Gao Q; Liu X; Hou L
    IUBMB Life; 2017 Jan; 69(1):16-21. PubMed ID: 27862841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of Runx2 phosphorylation in prostate cancer and association with metastatic disease.
    Ge C; Zhao G; Li Y; Li H; Zhao X; Pannone G; Bufo P; Santoro A; Sanguedolce F; Tortorella S; Mattoni M; Papagerakis S; Keller ET; Franceschi RT
    Oncogene; 2016 Jan; 35(3):366-76. PubMed ID: 25867060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyr61 expression is associated with prognosis in patients with colorectal cancer.
    Jeong D; Heo S; Sung Ahn T; Lee S; Park S; Kim H; Park D; Byung Bae S; Lee SS; Soo Lee M; Kim CJ; Jun Baek M
    BMC Cancer; 2014 Mar; 14():164. PubMed ID: 24606730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.